Kaitlyn Bader, Senior Editor

Adelaide Hebert, MD, reviewed ichthyosis, epidermolysis bullosa, molluscum contagiosum, and more at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

Bunick spoke at the Fall Clinical Dermatology Conference for PAs and NPs to discuss important considerations of biologics use for atopic dermatitis management.

Neal Bhatia, MD, will guide attendees at Fall Clinical PA & NP on the difference between JAKs and TYKs, as well as the role of PAs and NPs in clinical research.

Catch up on coverage from the first day of the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

The majority of patients with moderate-to-severe SD have a negatively impacted quality of life, according to a poster presentation from Fall Clinical for PAs and NPs.

Miller is presenting 3 sessions at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

No matter where you go, there is something for everyone to enjoy in Orlando after sessions have ended for the day at Fall Clinical for PAs and NPs.

The conference geared towards dermatology physician assistants and nurse practitioners begins today in Orlando, Florida.

Del Rosso and Stein Gold will discuss topical management in an in-depth seminar.

CEO Daniela Marino, PhD, emphasizes that the Switzlerand based company has received Orphan Drug Designation from the Swissmedic, EMA, and FDA, for its personalized human skin graft.

Weiss is the managing director of dermatology at OM1, a data analytics company with a health care focus.

Restylane Eyelight is the first and only US product that uses NASHA Technology to improve the appearance of undereye hollows for up to 18 months.

Principal investigator Jason Luke, MD, discusses what the new data means for melanoma treatment moving forward.

Apremilast is being examined for the treatment of psoriatic arthritis.

As senior director, Del Rosso is looking forward to presenting numerous sessions and welcoming attendees to Orlando.

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are popular for the month of May.

Cameron Dermatology, which just opened in NYC, will address both medical and cosmetic issues.

This week's edition of the Mainstream Patient features stories about 8 Black-owned holistic beauty brands, tear trough filler for under-eye bags, dermatologist-approved SPF-containing moisturizers, and more.

Learn more about the in-depth topics covered in the May 2023 issue of Dermatology Times®.

Learn from a panel of sun protection experts on how to effectively prepare your patients for the summer sun.

ICYMI, this week we had stories about more adalimumab biosimilars, brepocitinib for psoriatic arthritis, sunscreen screenings for veterans, and more.

This week's edition of the Mainstream Patient features stories about facial balancing, eyelid surgery 101, dermatologist-recommended sunscreen sticks, and more.

Yuflyma will be available to US patients in July 2023.

If you weren’t able to attend SCALE 2023 or want to review the latest data, our full recap has you covered.

The first-of-a-kind product uses a topically applied small peptide fluorescent dye and handheld imager to non-invasively detect a biomarker of early tissue changes.

The adalimumab biosimilar will be commercially available in the US starting July 1, 2023.

Catch up on coverage from the final day of SCALE 2023.

The over-the-counter serum helped improve skin recovery after laser treatment, according to a poster presentation at SCALE 2023.

Goldberg reviewed non-invasive skin tightening procedures and laser complications at SCALE 2023.

Catch up on coverage from the fourth day of SCALE 2023.